Open access
Open access
Powered by Google Translator Translator

Daily Archives: April 9, 2020

Thu April 09 – 10 Stories of The Day!

9 Apr, 2020 | 03:57h | UTC

 

1 – Coronavirus Q&A with Anthony Fauci, MD – JAMA

 

2 – Interview with Dr. Eric Rubin and Dr. Lindsey Baden on emerging tools in the fight against Covid-19. – New England Journal of Medicine

 

3 – Quarantine alone or in combination with other public health measures to control COVID‐19: a rapid review – Cochrane Library

Commentary: How effective is quarantine alone or in combination with other public health measures to control coronavirus (COVID-19)? – Cochrane Library

 

4 – The COVID-19 Coronavirus Disease May Be Twice As Contagious As We Thought – Forbes

Original Study: High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2 – CDC Emerging Infectious Diseases

 

5 – Chloroquine and hydroxychloroquine in covid-19 – Tue BMJ

“Use of these drugs is premature and potentially harmful”

 

6 – Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment – Circulation

News Release: Caution recommended on COVID-19 treatment with hydroxychloroquine and azithromycin for patients with cardiovascular disease – American Heart Association

Commentaries: Medical groups urge caution when using hydroxychloroquine, azithromycin to treat COVID-19 patients with CVD – Cardiovascular Business AND AHA, ACC, HRS Caution Use of COVID-19 Therapies Hydroxychloroquine and Azithromycin in Cardiac Patients – DAIC

 

7 – Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection – Canadian Medical Association Journal

Commentary: Potential harms of chloroquine, hydroxychloroquine and azithromycin for treating COVID-19 – Canadian Medical Association Journal

 

8 – [Preprint] Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters – medRxiv

Related perspectives from the same author:

Video: Perspectives on the Pandemic with Dr. John Ioannidis

Podcast: Be it resolved, we are making high-stakes decisions about the COVID-19 pandemic without reliable data. – Munk Debates Podcast

Editorial: Coronavirus disease 2019: the harms of exaggerated information and non‐evidence‐based measures – European Journal of Clinical Investigation

Opinion Piece: A fiasco in the making? As the coronavirus pandemic takes hold, we are making decisions without reliable data – STAT

 

9 – [Preprint] Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications – medRxiv

Commentaries: expert reaction to preprint (not a published paper) on antibody responses to the COVID-19 virus (SARS-CoV-2) in a group of recovered people in Shanghai – Science Media Centre AND Covid-19 Antibody Update for April 8 – Science Translational Medicine AND Coronavirus: low antibody levels raise questions about reinfection risk – South China Morning Post

 

10 – Coronavirus Disease (COVID-19) Updates / 09 April 2020 Edition

09 April 2020 Edition – COVID-19/SARS-CoV-2 Latest Articles, Guidelines, News & Perspectives (several free resources)

 


Study: The COVID-19 Coronavirus Disease May Be Twice As Contagious As We Thought

9 Apr, 2020 | 03:48h | UTC

The COVID-19 Coronavirus Disease May Be Twice As Contagious As We Thought – Forbes

Original Study: High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2 – CDC Emerging Infectious Diseases

 


Systematic Review: How Effective is Quarantine to Control Coronavirus (COVID-19)?

9 Apr, 2020 | 03:50h | UTC

Quarantine alone or in combination with other public health measures to control COVID‐19: a rapid review – Cochrane Library

Commentary: How effective is quarantine alone or in combination with other public health measures to control coronavirus (COVID-19)? – Cochrane Library

 


Video: Coronavirus Q&A with Anthony Fauci, MD

9 Apr, 2020 | 03:54h | UTC

Coronavirus Q&A with Anthony Fauci, MD – JAMA

 


Podcast: Emerging Tools in the Fight Against Covid-19

9 Apr, 2020 | 03:53h | UTC

Interview with Dr. Eric Rubin and Dr. Lindsey Baden on emerging tools in the fight against Covid-19. – New England Journal of Medicine

 


Editorial: Chloroquine and Hydroxychloroquine in Covid-19

9 Apr, 2020 | 03:47h | UTC

Chloroquine and hydroxychloroquine in covid-19 – Tue BMJ

“Use of these drugs is premature and potentially harmful.”

 


Study: Population-level COVID-19 Mortality Risk

9 Apr, 2020 | 03:38h | UTC

[Preprint] Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters – medRxiv

“CONCLUSIONS: People <65 years old have very small risks of COVID-19 death even in the hotbeds of the pandemic and deaths for people <65 years without underlying predisposing conditions are remarkably uncommon. Strategies focusing specifically on protecting high-risk elderly individuals should be considered in managing the pandemic.”

Related perspectives from the same author:

Video: Perspectives on the Pandemic with Dr. John Ioannidis

Podcast: Be it resolved, we are making high-stakes decisions about the COVID-19 pandemic without reliable data. – Munk Debates Podcast

Editorial: Coronavirus disease 2019: the harms of exaggerated information and non‐evidence‐based measures – European Journal of Clinical Investigation

Opinion Piece: A fiasco in the making? As the coronavirus pandemic takes hold, we are making decisions without reliable data – STAT

 


AHA Guidance: Caution Recommended on COVID-19 Treatment with Hydroxychloroquine and Azithromycin for Patients with Cardiovascular Disease

9 Apr, 2020 | 03:45h | UTC

Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment – Circulation

News Release: Caution recommended on COVID-19 treatment with hydroxychloroquine and azithromycin for patients with cardiovascular disease – American Heart Association

Commentaries: Medical groups urge caution when using hydroxychloroquine, azithromycin to treat COVID-19 patients with CVD – Cardiovascular Business AND AHA, ACC, HRS Caution Use of COVID-19 Therapies Hydroxychloroquine and Azithromycin in Cardiac Patients – DAIC

 


Safety Considerations with Chloroquine, Hydroxychloroquine and Azithromycin in the Management of SARS-CoV-2 Infection

9 Apr, 2020 | 03:42h | UTC

Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection – Canadian Medical Association Journal

Commentary: Potential harms of chloroquine, hydroxychloroquine and azithromycin for treating COVID-19 – Canadian Medical Association Journal

 


Antibody Responses to SARS-CoV-2 in a COVID-19 Recovered Patient Cohort

9 Apr, 2020 | 03:34h | UTC

[Preprint] Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications – medRxiv

Commentaries: expert reaction to preprint (not a published paper) on antibody responses to the COVID-19 virus (SARS-CoV-2) in a group of recovered people in Shanghai – Science Media Centre AND Covid-19 Antibody Update for April 8 – Science Translational Medicine AND Coronavirus: low antibody levels raise questions about reinfection risk – South China Morning Post

 


Editorials: Covid-19 Testing Times

9 Apr, 2020 | 03:26h | UTC

Covid-19: testing times – The BMJ

See also: Humanity tested – Nature Biomedical Engineering

 


PCR Assays May Turn Positive After Discharge

9 Apr, 2020 | 03:29h | UTC

PCR Assays Turned Positive in 25 Discharged COVID-19 Patients – Clinical Infectious Diseases

 

Related Commentary on Twitter

 


Disruptive Opinion on the Use of Ventilators in COVID-19

9 Apr, 2020 | 03:22h | UTC

With ventilators running out, doctors say the machines are overused for Covid-19 – STAT

Related: COVID-19 pneumonia: different respiratory treatment for different phenotypes? – Intensive Care Medicine AND Covid-19 Does Not Lead to a “Typical” Acute Respiratory Distress Syndrome – American Journal of Respiratory and Critical Care Medicine

 


Taking Care of COVID-19 Survivors

9 Apr, 2020 | 03:17h | UTC

For survivors of severe COVID-19, beating the virus is just the beginning – Science

 


Case Reports: Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

9 Apr, 2020 | 03:20h | UTC

Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19 – New England Journal of Medicine

 


Report: Coronavirus Pandemic May Not Fade in Summer Weather

9 Apr, 2020 | 03:14h | UTC

Coronavirus Pandemic May Not Fade in Summer Weather – The New York Times

Original Report: Rapid Expert Consultation on SARS-CoV-2 Survival in Relation to Temperature and Humidity and Potential for Seasonality for the COVID-19 Pandemic (April 7, 2020) – National Academies of Sciences, Engineering and Medicine

 


Severity of COVID-19 in Children

9 Apr, 2020 | 03:19h | UTC

Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid, Spain – JAMA Pediatrics

Commentary: Children at low risk for COVID-19, but can get seriously ill, new data show – UPI

 


[Abstract Only] Randomized Trial: Physical Therapy versus Glucocorticoid Injection for Osteoarthritis of the Knee

9 Apr, 2020 | 03:13h | UTC

Physical Therapy versus Glucocorticoid Injection for Osteoarthritis of the Knee – New England Journal of Medicine (link to abstract – $ for full-text)

Visual Abstract: Physical Therapy vs. Glucocorticoid Injection for Knee Osteoarthritis – New England Journal of Medicine

 


Trials of Drugs to Prevent Coronavirus infection Begin in Health Care Workers

9 Apr, 2020 | 03:16h | UTC

Trials of drugs to prevent coronavirus infection begin in health care workers – Science

 


Case Report: Acute Myocarditis Presenting as a Reverse Tako-Tsubo Syndrome in a Patient with Covid-19

9 Apr, 2020 | 03:15h | UTC

Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection – European Heart Journal

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.